Trametinib Dimethyl Sulfoxide
Brand name: Mekinist
Rank #317 of 500 drugs by total cost
$35.0M
Total Cost
2,448
Total Claims
$35.0M
Total Cost
161
Prescribers
$14K
Cost per Claim
11
Beneficiaries
2,454
30-Day Fills
$217K
Avg Cost/Provider
15
Avg Claims/Provider
About Trametinib Dimethyl Sulfoxide
Trametinib Dimethyl Sulfoxide (sold as Mekinist) was prescribed 2,448 times by 161 Medicare Part D providers in 2023, costing the program $35.0M. At $14K per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 314 | Lisdexamfetamine Dimesylate (Lisdexamfetamine Dimesylate) | $35.7M | 88,692 |
| 315 | Ketoconazole (Ketoconazole) | $35.4M | 1,346,512 |
| 316 | Oxcarbazepine (Oxcarbazepine) | $35.3M | 430,248 |
| 317 | Trametinib Dimethyl Sulfoxide (Mekinist) | $35.0M | 2,448 |
| 318 | Isosorbide Mononitrate (Isosorbide Mononitrate Er) | $34.5M | 1,805,114 |
| 319 | Clonazepam (Clonazepam) | $34.4M | 3,685,968 |
| 320 | Tolvaptan (Jynarque) | $34.4M | 2,760 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology